There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Also, Merck & Co. discontinues development of its obesity drug taranabant; Synthetech names Frederic Farkas director of manufacturing; more...

Company and People Notes: Azopharma Expands Analytical Lab; Inotek Pharma Appoints Paul G. Howes President, CEO, and Director; More...

Angie Drakulich was editorial director of Pharmaceutical Technology.

Advancements add yet another challenge for industry's already overextended regulatory body.

Complex Science

Brief pharmaceutical news items for October 2008.

Pharma Capsules

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Can previous trends of Democratic and Republican administrations predict industry's future?

The Past as Prologue

Also, Alpharma advises shareholders to reject King's offer; ImClone rejects raised BMS offer; Immunogen appoints Daniel M. Junius, more...

Company and People Notes: GSK to Cut up to 850 Jobs; Zerhouni to Leave NIH; More...

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

The growth and globalization of the pharmaceutical supply chain make risk assessment more important than ever for pharmaceutical manufacturers. The authors describe a program to identify, prioritize, mitigate, and communicate risks in manufacturer–supplier relationships.

Risk Management within the Global Supply Chain

The biggest benefit of PAT and the current FDA initiatives may be in allowing pharmaceutical scientists to use their technical capabilities to improve pharmaceutical processes.

PAT — a team effort

Also, Zentiva accepts Sanofi's increased takeover bid, Oriel Therapeutics appoints Richard Fuller CEO, more...

Company and People Notes: Committee on Energy and Commerce Expands Ranbaxy Probe; Eli Lilly Appoints John C. Lechleiter Chairman of the Board; More...

Also, Quintiles to expand Singapore operations; Christine A. Poon, chairman of Johnson & Johnson's pharmaceuticals group, to retire; more...

Company and People Notes: King Commences Tender Offer for Alpharma; Genentech Appoints Morgan Sheng VP of Neuroscience; More...

Also, Human Genome Sciences enters pact with Hospira, Zosano Pharma names Gail Schulze chair and CEO, more...

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes